Khangela elona naliti lihle kakhulu lwesikhumba kwaye uya kudibana namagama amathathu afanayo: i-glutathione, i-vitamin C (i-ascorbic acid) kunye ne-tranexamic acid (TXA). Iiklinikhi zihlala zizibonisa 'njengezithonga eziqaqambileyo' ezitshintshayo, kodwa zisebenza ngeendlela ezahlukeneyo, zihanjiswa ngeendlela ezahlukeneyo kwaye zinemigangatho eyahluke kakhulu yobungqina. Ngoko ke yeyiphi eqaqambisa ulusu kakuhle? Impendulo enyanisekileyo ixhomekeke kwingxaki yebala ephathwayo.
Kweli nqaku, 'ukuqaqamba' kuthetha ithoni yangokuhlwa kunye nokuncipha kwebala lebala elifana ne-melasma, amabala elanga okanye amanqaku asemva kokudumba. Oku akuthethi ukutshintsha ibala lomntu lendalo, elimiselwe ngokwemizila yemfuza, yaye akukho nasinye kwezi zithako esinokukwenza oko ngokusisigxina. Ngezantsi uya kufumana itafile yokuthelekisa ngecala, iphrofayili emfutshane yesithako ngasinye, isikhokelo sesigqibo ngokukhathazeka kwesikhumba kunye neendawo eziphambili zokhuseleko kunye nokulawula ukuba iiklinikhi kunye nabasasazi kufuneka bazi.
IGlutathione vs Vitamin C vs Tranexamic Acid: Itheyibhile yokuthelekisa
Umba |
I-Glutathione (GSH) |
Ivithamin C (ascorbic acid) |
I-Tranexamic acid (TXA) |
Indlela engundoqo |
i-tripeptide ye-Antioxidant; inqanda i-tyrosinase ngokuthe ngqo kwaye ngokungathanga ngqo kwaye iguqule imveliso ye-melanin ukusuka kwi-eumelanin emnyama ukuya kwi-pheeomelanin ekhanyayo |
I-Antioxidant; inqanda i-tyrosinase ngokusebenzisana nobhedu kwindawo esebenzayo ye-enzyme, ukunciphisa ukubunjwa kwe-melanin. |
I-Plasmin inhibitor; iphazamisa indlela ye-plasminogen-plasmin edibanisa ukuvezwa kwe-UV kunye neeseli zesikhumba kwi-melanocyte stimulation. |
Isetyenziswa njani |
Iipilisi zomlomo okanye i-lozenges, i-creams topical creams; Iidriphu ze-IV zithandwa kodwa zingekho-ileyibheli; ngamanye amaxesha wongezwa kwi-cocktails ye-mesotherapy ye-intradermal |
iiserum zezihloko; i-mesotherapy ye-intradermal okanye i-microneedling ye-pigment; I-high-dose ye-IV infusions yinto eyahlukileyo, ukusetyenziswa kwenkqubo |
I-Intradermal microinjection okanye i-mesotherapy kwisilonda, i-microneedling, i-topical, kunye nomlomo (umyalelo) |
Eyona nto ifanelekileyo |
Ubuthuntu ngokubanzi kunye nenkxaso ye-antioxidant, njenge-add-on |
Ubuthuntu, ukonakala kwefoto kunye ne-epidermal pigment ephakathi; iqabane eliqhelekileyo kwi-TXA |
I-Melasma kunye nenkani, ihomoni- okanye i-UV-driven pigment ebusweni |
Umgangatho wobungqina |
I-RCT encinci yomlomo kunye neengqungquthela zibonisa ukuthotywa kwe-melanin-index index; Uphononongo olunye kuphela lwe-IV olubuthathaka olulawulwa yi-placebo, olwalungabalulekanga |
Ulingo oluncinci kunye nohlalutyo lwe-meta luka-2024 lubonisa i-mesotherapy enevithamin C yenza ngokufanayo ne-TXA mesotherapy kwi-melasma. |
Awona mandla mathathu e-melasma, nangona izifundo ezininzi zokutofa zisencinci kwaye zifutshane |
Amanqaku angundoqo okhuseleko |
Ukusetyenziswa kwe-IV okudityaniswe nesibindi, izintso kunye nokuphendula kwesikhumba kwizilumkiso zokulawula; akukho dosing ye-IV evunyiweyo yokukhanyisa ulusu |
Ukusetyenziswa kwe-Intradermal kunokuhlaba okanye ukutshisa; Ukusetyenziswa kwedosi ephezulu ye-IV kuthwala amatye entso kunye neenkxalabo zokunqongophala kwe-G6PD |
Ububomvu bendawo, ukugruzuka kunye nokungakhululeki; Ukuhlola umngcipheko wokujiya kuyindlela eqhelekileyo ngaphambi kokusetyenziswa kwenkqubo |
Iindibaniso eziqhelekileyo |
Ifakwe kwi-TXA + i-cocktails yevithamin C |
Idityaniswe ne-TXA, kunye okanye ngaphandle kweglutathione |
Isithako esisisiseko sezona cocktails ezininzi ze-melasma |
I-Glutathione: Idumile, kodwa ubungqina buncinci
I-Glutathione yi-antioxidant yendalo efumaneka ngaphakathi phantse kuzo zonke iiseli. Uphononongo luchaza umphumo walo wokukhanya njengokuvela ngokuthe ngqo kunye nokungathanga ngqo kwe-tyrosinase kunye nokutshintsha i-melanin synthesis ukuya kwi-pigment elula (Sonthalia et al., 2016). Kwizifundo ezilawulwayo, nangona kunjalo, umphumo uthobekile. Ulingo olungenamkhethe, oluyimfama oluphindwe kabini kumavolontiya e-Thai e-60 lufumene ukuba i-500 mg ye-glutathione yomlomo imihla ngemihla kwiiveki ezine yanciphisa i-melanin indices ngaphezu kwe-placebo kwiindawo ezimbini kuphela ezintandathu (Arjinpathana kunye ne-Asawanonda). Uphononongo oluvulekileyo lweleyibhile ye-buccal lozenge kwi-30 yabasetyhini bakwiiPhilippines baphinde baxela ukuwa kwe-melanin indices, kodwa yayingenalo iqela le-placebo (Handog et al., 2016).
Ubungqina be-glutathione nge-intravenous buthathaka ngakumbi. Uphando lwe-IV olulawulwa yi-placebo kuphela alufumananga mmahluko obalulekileyo kwi-saline (37.5% vs 18.7% iphuculwe, p = 0.054), ukuphuculwa kwaphela kwiinyanga ezintandathu, kwaye abathathi-nxaxheba abaninzi babenovavanyo olungaqhelekanga lwesibindi okanye i-anaphylaxis (Zubair et al., 2016). Uphononongo olucwangcisiweyo luka-2024 lwagqiba ekubeni i-IV glutathione ichasene nokukhanya kwesikhumba kwaye i-glutathione 'inokusebenza ngakumbi njenge-antioxidant kwi-melasma' (uSarkar et al.). Ukuze ufumane imvelaphi enobubele, jonga yethu Isikhokelo sendlela i-glutathione yesikhumba esimhlophe esisebenza ngayo.
I-Vitamin C: I-Antioxidant Partner
I-Ascorbic acid yenza i-radicals yamahhala eveliswa kukukhanya kwe-UV kwaye inqanda i-tyrosinase, yiyo loo nto kudala isetyenziselwa ukuguga kweefoto kunye ne-hyperpigmentation (Telang, 2013). Ubuthathaka bayo obuphambili kukuhanjiswa: i-vitamin C ayizinzile kwaye inzima ukungena kwidermis kwiindawo ezincedo, ezichaza umdla kwi-mesotherapy kunye ne-microneedling.
Xa ivithamin C itofwe nge-intradermally ye-melasma, iyazibamba. Uhlalutyo lwe-meta lwango-2024 lwezifundo ezihlanu (izigulana ezili-127) zafumanisa ukuba akukho mahluko ubalulekileyo ngokwezibalo kuphuculo lwe-MASI phakathi kwe-TXA mesotherapy kunye ne-vitamin C mesotherapy kwaye yagwetywa zombini ukuba zikhuselekile (Liao et al.). Amaphononongo ayemancinci, ngoko ke oku kufundwa ngcono ngokuthi 'kuthelekiseka phakathi kwedatha enyiniweyo' kunobungqina bokulingana.
I-Tranexamic Acid: Ingcali yeMelasma
I-Tranexamic acid yaphuhliswa njengeyeza lokunciphisa ukopha. Indima yayo kwi-pigment ivela ekuthinteleni umsebenzi we-plasmin, indlela ebandakanyekayo kwi-UV-ibangele i-melanocyte isebenze. Kwisifundo sokuqala se-intradermal, abafazi be-85 baseKorea bafumana ngeveki i-4 mg / mL microinjections kwizilonda ze-melasma kwiiveki ze-12; umlinganiselo we-MASI wamanqaku wehla ukusuka kwi-13.22 ukuya kwi-7.57 kunye nemiphumo emincinci (Lee et al., 2006). Olo phando lwalungenalo iqela lokulawula. Ulingo olwenziwayo kamva kwizigulane ze-60 zifumene i-35.72% yokuphucula i-MASI kunye ne-TXA microinjections kunye ne-44.41% kunye ne-TXA ehanjiswa yi-microneedling, kungekho ziganeko ezimbi kakhulu (Budamakuntla et al., 2013).
Iinkcukacha zeProtocol, amaxesha eseshoni kunye nokukhethwa kwesigulane kubandakanywa kwinqaku lethu elizinikeleyo I-tranexamic acid mesotherapy ye-melasma , ngoko asiyi kuphinda apha.
Yeyiphi Elungileyo? ISikhokelo seSigqibo ngokuKhathalela ulusu
Akukho naliti enye ingcono yokwenza mhlophe. Ukhetho olufanelekileyo lulandela ukuxilongwa:
I-Melasma
I-TXA sisithako sokuqala uninzi lweengcali zedermatologists ezifikelela kuyo, zisiwe kwi-intradermally okanye nge-microneedling, ecaleni kokhuseleko olungqongqo lwelanga. IVithamin C mesotherapy yeyona ndlela ifanelekileyo okanye iqabane, linikwe iziphumo ezithelekisekayo kuhlalutyo lwemeta. I-Glutathione yinto yokongeza, kungekhona impendulo yodwa.
Ubuthuntu ngokubanzi kunye nethoni engalinganiyo
Kulusu oludiniweyo, oluluqilima okanye olonakaliswe yifoto ngaphandle kokuphazamiseka kwe-pigment echaziweyo, eyona nto ibaluleke kakhulu yinkxaso ye-antioxidant. I-Vitamin C iyona nto ingundoqo, kwaye i-glutathione inokufaka isandla kwinzuzo ye-antioxidant. Okulindelekileyo kufuneka kufakwe kwifreyim 'ngokutsha, ngakumbi ulusu', hayi ibala elikhaphukhaphu.
I-Post-inflammatory hyperpigmentation (PIH)
Amanqaku ashiywe emva kwe-acne okanye ukucaphuka ahlala ephela ngokuhamba kwexesha, ukukhuselwa kwelanga kunye nokunyamekela okuthambileyo. Ukuba iinaliti zisetyenzisiwe, iiprothokholi ezicaphuka kancinci ezinevithamin C okanye i-TXA ziyavakala, kuba unyango olundlongo-ndlongo lunokubangela ibala elitsha lebala. Isishwankathelo sethu se izitofu ezikhazimlisa ulusu zehyperpigmentation zichaza ezona ntlobo zepigment ziphambili ngokweenkcukacha.
Inkxaso ye-Antioxidant malunga nezinye iinkqubo
I-Vitamin C kunye ne-glutathione zihlala zikhethwa njengezithako ezixhasayo malunga ne-lasers okanye iipeel. Aziyithathi indawo yesicwangciso sonyango esikhethekileyo.
Ngenxa yokuba izithako ezithathu zisebenza kumanyathelo ahlukeneyo okwakhiwa kwe-pigment, iifomyula ezikhanyayo zanamhlanje zihlala zidibanisa i-TXA, i-vitamin C kunye ne-glutathione kunokukhetha enye. Idatha yeklinikhi ixhasa le ngqiqo, ubuncinane kwizilingo ezincinci. Kwilingo eliphindwe kabini elingaboniyo, elijongene nezigulane ze-melasma ze-24, i-TXA kunye ne-ascorbic acid yehlisa amanqaku e-MASI ngaphezu kwe-TXA kunye ne-placebo kwiiveki ze-8 kunye ne-12, nangona intlungu evuthayo yayiphawuleka ngakumbi kwicala lokudibanisa (Pazyar et al., 2022). Kwesinye isilingo sobuso obuhlukeneyo bezigulane ze-30, i-cocktail ye-TXA 4 mg / mL, i-vitamin C 3% kunye ne-glutathione i-2% yanciphisa i-mMASI ngaphezu kwe-TXA kunye ne-vitamin C yodwa, kunye namazinga afanayo obomvu, ukuvuvukala kunye nokubetha (Iraji et al., 2019).
Ukufumana isingeniso esibanzi malunga nendlela ezi mveliso ezibekwe ngayo, funda yethu isikhokelo seenaliti ezimhlophe kunye nokuqaqamba kolusu.
Ukhuseleko kunye noMgaqo
I-IV glutathione ayilochiza elivunyiweyo lokuthambisa ulusu kwiimarike ezininzi. Kwingcebiso ka-2019, i-FDA yasePhilippine yathi ayikhange ivume nayiphi na imveliso etofwayo yokukhanyisa ulusu, ivunyiwe i-glutathione etofwayo kuphela njenge-adjunct kwi-cisplatin chemotherapy, kwaye yalumkisa ngeziphumo zesibindi, izintso kunye ne-nervous-system kunye nesifo sikaStevens-Johnson.
Idosi ephezulu ye-IV yevithamin C inomngcipheko wayo. Ingcebiso efanayo yaphawula ukuba iinaliti ze-vitamin C zinokwenza amatye ezintso kwaye iidosi ezinkulu zikhokelele kwi-hemodialysis kubantu abane-G6PD yokusilela.
Izitofu zendawo azikho mngcipheko. Lindela ukuba bomvu okwethutyana, ukuhlaba, ukudumba okanye ukugruzuka. Ubuchule obunyumba nobunzulu obuchanekileyo bubalulekile.
Iziphumo azinasigxina. I-pigment iyabuya ukuba ukuvezwa kwe-UV, iihomoni okanye ukudumba kuyaqhubeka. Ukhuseleko lwelanga olubanzi lwemihla ngemihla luyinxalenye yeprothokholi nganye.
Yazi imithetho yendawo yakho. Ukubhaliswa kwemveliso kwaye ngubani onokutofa ngokwahlukileyo ngokwelizwe. Unyango kufuneka lumiselwe kwaye lunikwe ngabasebenzi abaqeqeshiweyo.
Kwiiklinikhi kunye naBasasazi
Iiklinikhi zibona iziphumo ezingcono kunye nezikhalazo ezimbalwa xa zifumanisa uhlobo lwe-pigment kuqala, khetha iiprothokholi ezisekwe kwi-TXA ze-melasma kwaye zibonise i-glutathione ngokunyanisekileyo njenge-antioxidant adjunct kunokutshintsha umbala wolusu. Abasasazi kufuneka bajonge ukuba ubhaliso lwemveliso nganye kunye nokuleyibhelishwa kwayo kuyahambelana na nemarike ekujoliswe kuyo.
I-AOMA yenza izisombululo ezikhanyayo ze-mesotherapy, kuquka i-TXA, i-vitamin C kunye neefomyula ezidibeneyo, ukubonelela ngesitokhwe kunye ne-OEM. Ungakhangela kwi Uluhlu lwenaliti emhlophe ye-AOMA yesikhumba . I-MOQ iqala kwiiyunithi ezingama-200 kuzo zombini isitokhwe kunye neodolo ye-OEM. Iiodolo zesitokhwe zithunyelwa ngenqanawa ngaphakathi kweeyure ezingama-24, kwaye ixesha lokukhokela kwe-OEM ziiveki ezi-2-3 emva komsebenzi wobugcisa, ifomula kunye neenkcukacha zokupakishwa ziqinisekisiwe. I-AOMA ibambe i-CE, i-ISO 13485, i-GMP kunye nezatifikethi ze-FDA.
FAQ
Yeyiphi eyona naliti yokwenza mhlophe?
Akukho ophumeleleyo omnye. Kwi-melasma, i-tranexamic acid ineyona datha yenaliti yenkxaso. Ngokuba buthuntu jikelele, ivithamin C lukhetho olunengqiqo lwe-antioxidant. IGlutathione yeyona nto yokongeza. Ugqirha kufuneka axilonge ingxaki yebala phambi kokuba akhethe.
Ngaba i-glutathione ingcono kunevithamin C yokuqaqambisa ulusu?
Hayi ngokucacileyo. Zombini zinobungqina obuncinci, bexesha elifutshane. IVithamin C inedatha yenaliti eninzi ye-melasma, ngelixa i-IV glutathione iye yasilela ukubetha i-placebo kulingo lwayo olulawulwayo kuphela.
Ngaba i-tranexamic acid, ivithamin C kunye neglutathione zinokutofwa kunye?
Ewe, i-cocktails edibeneyo ixhaphakile, kwaye iimvavanyo ezincinci zobuso obuhlukeneyo zifumene ukuba ukongeza i-vitamin C, kunye ne-glutathione, kwi-TXA iphucule amanqaku e-melasma. Ukutshisa okanye ukuhlaba kunokunyuka kunye nokudibanisa.
Ngaba iinaliti ezimhlophe zitshintsha ngokusisigxina umbala wolusu?
Hayi. Ziyakwazi ukucima i-pigment egqithisileyo kunye nethoni engaphandle, kodwa azitshintshi umbala wolusu lwendalo, kwaye iziphumo ziyaphela ngaphandle kokukhuselwa kwelanga kunye nokugcinwa.
Ngaba i-IV glutathione ikhuselekile ekwenzeni mhlophe ulusu?
Abalawuli abanje ngePhilippine FDA balumkise ngokuchasene nayo, kwaye uphononongo olucwangcisiweyo luka-2024 luthathelwe ingqalelo i-IV glutathione echasene nokukhanya kwesikhumba ngenxa yokungabikho kokusebenza kunye neziphumo ebezingalindelekanga.
Iimbekiselo
Lee JH, Park JG, Lim SH, et al. I-intradermal microinjection yendawo ye-tranexamic acid yonyango lwe-melasma kwizigulane zase-Asia: ulingo lokuqala lweklinikhi. I-Dermatol Surg . 2006;32(5):626–631. PMID: 16706756.
Budamakuntla L, Loganathan E, Suresh DH, et al. I-randomized, i-open-label, isifundo sokuthelekisa i-tranexamic acid microinjections kunye ne-tranexamic acid ene-microneedling kwizigulane ezine-melasma. J Cutan Aesthet Surg . 2013;6(3):139–143. PMID: 24163529.
U-Liao X, u-Cheng F, u-Jiang Y. Ukusebenza kunye nokhuseleko lwe-mesotherapy kunye ne-tranexamic acid ngokuchasene ne-vitamin C kunyango lwe-melasma: uhlalutyo lwe-meta kunye nokuhlaziywa kwenkqubo. J Cosmet Dermatol . 2024;23(9):2785–2792. PMID: 38693699.
Pazyar N, Molavi SN, Hosseinpour P, et al. Ukusebenza kwenaliti ye-intradermal ye-tranexamic acid kunye ne-ascorbic acid ngokuchasene ne-tranexamic acid kunye ne-placebo kunyango lwe-melasma: uvavanyo lokuthelekisa ubuso obuhlukeneyo. Health Sci Rep . 2022;5(2):e537. PMID: 35284654.
Iraji F, Nasimi M, Asilian A, et al. Ukusebenza kwe-mesotherapy kunye ne-tranexamic acid kunye ne-ascorbic acid kunye kunye nangaphandle kwe-glutathione kunyango lwe-melasma: uvavanyo lokuthelekisa ubuso obuhlukeneyo. J Cosmet Dermatol . 2019;18(5):1416–1421. PMID: 30735611.
I-Sonthalia S, i-Daulatabad D, i-Sarkar R. Glutathione njenge-agent emhlophe yesikhumba: amaqiniso, iinkolelo, ubungqina kunye neengxabano. Indian J Dermatol Venereol Leprol . 2016;82(3):262–272. PMID: 27088927.
Sarkar R, Yadav V, Yadav T, et al. I-Glutathione njenge-agent ekhanyisa ulusu kunye ne-melasma: uphononongo olucwangcisiweyo. Int J Dermatol . 2025; 64 (6): 992-1004 (kwi-intanethi 2024). PMID: 39444151.
U-Arjinpathana N, u-Asawanonda P. Glutathione njenge-agent yomlomo omhlophe: i-randomized, i-double-blind, i-placebo-controlled controlled study. J Dermatolog Unyango . 2012;23(2):97–102. PMID: 20524875.
Handog EB, Datuin MS, Singzon IA. Ileyibhile evulekileyo, isilingo sengalo enye yokhuseleko kunye nokusebenza kakuhle kwenoveli yokulungiselela i-glutathione njenge-agent ekhanyisa ulusu kubasetyhini basePhilippines. Int J Dermatol . 2016;55(2):153–157. PMID: 26148180.
Zubair S, Hafeez S, Mujtaba G. Ukusebenza kwe-intravenous glutathione vs. I-placebo yokukhanya kwethoni yesikhumba. J Pak Assoc Dermatol . 2016;26(3):177. https://jpad.com.pk/index.php/jpad/article/view/18
Telang PS. I-Vitamin C kwi-dermatology. Indian Dermatol Online J. 2013;4(2):143–146. PMID: 23741676.
Ukutya kunye noLawulo lweziyobisi kwiiPhilippines. I-FDA Advisory No. 2019-182: Ukusetyenziswa okungakhuselekanga kwe-glutathione njenge-agent ekhanyisa ulusu. 2019. https://www.fda.gov.ph/fda-advisory-no-2019-182-unsafe-use-of-glutathione-as-skin-lightening-agent/
Eli nqaku lenzelwe iinjongo zemfundo kuphela kwaye ayilona cebiso lonyango. Unyango olukhanyayo olutofwayo kufuneka luhlolwe kwaye lwenziwe ngabasebenzi abaqeqeshiweyo ngokuhambelana nemimiselo yendawo.
